CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 19 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-03 | Clark Wesley Director | Grant or award · Stock Option (right to buy) | +21,873 | 21,873 | ||
| 2021-05-03 | Brennan John Owen Director | Grant or award · Stock Option (right to buy) | +21,873 | 21,873 | ||
| 2021-03-09 | Adcock Richard Chief Executive Officer | Other acquisition · Restricted Stock Units | +172,420 | 172,420 | ||
| 2021-03-09 | SOON-SHIONG PATRICK Executive Chairman | Other acquisition | +5,723,182 | 29,473,932 | ||
| 2021-03-09 | SOON-SHIONG PATRICK Executive Chairman | Other acquisition | +221,130,000 | 261,705,814 | ||
| 2021-03-09 | SOON-SHIONG PATRICK Executive Chairman | Other acquisition | +8,383,414 | 8,383,414 | ||
| 2021-03-09 | SOON-SHIONG PATRICK Executive Chairman | Other acquisition | +7,976,159 | 7,976,159 | ||
| 2021-02-05 | Adcock Richard Chief Executive Officer | Option exercise | +150,000 | 150,000 | ||
| 2021-02-05 | Adcock Richard Chief Executive Officer | Shares withheld for taxes | −68,171 | $23.72 | $1.6M | 81,829 |
| 2021-02-05 | Adcock Richard Chief Executive Officer | Grant or award · Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2021-02-05 | Adcock Richard Chief Executive Officer | Grant or award · Restricted Stock Units | +250,000 | 250,000 | ||
| 2021-02-05 | Adcock Richard Chief Executive Officer | Grant or award · Restricted Stock Units | +150,000 | 150,000 | ||
| 2021-02-05 | Adcock Richard Chief Executive Officer | Option exercise · Restricted Stock Units | −150,000 | 0 | ||
| 2021-02-05 | Simon Barry J. See remarks | Option exercise | +22,100 | $2.00 | $44K | 3,192,640 |
| 2021-02-05 | Simon Barry J. See remarks | Sale | −22,100 | $23.09 | $510K | 3,170,540 |
| 2021-02-05 | Simon Barry J. See remarks | Option exercise · Stock Option (right to buy) | −22,100 | 110,020 | ||
| 2021-02-02 | Simon Barry J. See remarks | Option exercise | +82,070 | $2.00 | $164K | 3,252,610 |
| 2021-02-02 | Simon Barry J. See remarks | Sale | −82,070 | $20.65 | $1.7M | 3,170,540 |
| 2021-02-02 | Simon Barry J. See remarks | Option exercise · Stock Option (right to buy) | −82,070 | 132,120 | ||
| 2021-01-28 | Simon Barry J. See remarks | Option exercise | +11,304 | $2.00 | $23K | 3,181,844 |
Page 14 of 22 · 433 trades